TGFβR2 Is a Major Target of miR-93 in Nasopharyngeal Carcinoma Aggressiveness

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-51
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interleukin 35 Is an Independent Prognostic Factor and a Therapeutic Target for Nasopharyngeal Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2015English

Dysregulation of the MiR-449b Target TGFBI Alters the TGFβ Pathway to Induce Cisplatin Resistance in Nasopharyngeal Carcinoma

Oncogenesis
Cancer ResearchMolecular Biology
2018English

miR-206 Enhances Nasopharyngeal Carcinoma Radiosensitivity by Targeting IGF1

Kaohsiung Journal of Medical Sciences
Medicine
2017English

Hsp70-2 Is Highly Expressed in Nasopharyngeal Carcinoma and Involved in Nasopharyngeal Carcinoma Invasiveness

Clinical Oncology and Research
2020English

Predictive Value of miR-9 as a Potential Biomarker for Nasopharyngeal Carcinoma Metastasis

British Journal of Cancer
Cancer ResearchOncology
2013English

MiR-34b-3 and miR-449a Inhibit Malignant Progression of Nasopharyngeal Carcinoma by Targeting Lactate Dehydrogenase A

Oncotarget
Oncology
2016English

P-Cadherin Is a Direct PAX3–FOXO1A Target Involved in Alveolar Rhabdomyosarcoma Aggressiveness

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

MiR-1204 Sensitizes Nasopharyngeal Carcinoma Cells to Paclitaxel Bothin Vitroandin Vivo

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2015English

MicroRNA Profiling Study Reveals miR-150 in Association With Metastasis in Nasopharyngeal Carcinoma

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy